Akeso, Inc. (9926.HK) ('Akeso' or the 'Company') announced the presentation of a Phase II clinical study that included a longer-term efficacy data evaluating ivonescimab (a PD-1/VEGF bispecific ...
Recent supply-chain breaches show how attackers exploit development tools, compromised credentials, and malicious NPM ...
Coventry, UK – December 10, 2025 – PRESSADVANTAGE – Strongway Gym Supplies has announced the release of a newly developed hex ...
Australian activewear brand Nimble is in hot water this week after a new campaign for its 'In Pace' running range sparked ...
Revenue for FY 2025 was $63.8 million, compared to $44.6 million in the fiscal year ended September 30, 2024 ("FY 2024"). An increase of $19.2 million or 43% year over year. Revenue for Q4 2025 was ...
An us-versus-them mentality has emerged between Meta’s top artificial intelligence team and longtime lieutenants to Mark ...
An infinitesimal 0.001 percent of the world’s population, 56,000 people, control three times more wealth than the poorest ...
The surge of investment grade AI infrastructure debt has mesmerized fixed income investors, but the non-investment grade ...
Emirates News Agency on MSN
UAE Government issues Federal Decree-Law on veterinary medical products, veterinary pharmaceutical establishments
The UAE government has issued a Federal Decree-Law on Veterinary Medical Products and Veterinary Pharmaceutical ...
PCMag Australia on MSN
I Tried the New Android XR Smart Glasses From Google and XReal. I Didn't Expect to Be This Impressed
Google's Android XR platform and XReal's Project Aura are bringing smart glasses closer to mainstream reality, offering ...
Zealand Pharma A/S (Nasdaq: ZEAL) is a biotechnology company focused on advancing medicines for obesity and metabolic health. Combining more than 25 years of peptide R&D expertise with a proprietary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback